# Grainger – FDA Inspection, Mar 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/grainger/6c1338b1-38f6-47d3-9125-49d02f24b1d4
Source feed: FDA_Inspections

> FDA inspection 1264387 of Grainger, March 05, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264387
- Company Name: Grainger
- Inspection Date: 2025-03-05
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1209662 - 2023-06-16

## Related Officers

- [Company Rep](https://www.keypedia.com/people/corrine-m-carter/69e1be8c-1cd9-48d9-a08e-bf49060b94d6)

Company: https://www.keypedia.com/companies/grainger/6bcb1fd7-96f0-4dd2-873c-f42d6c4b31ee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c